Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer

Peer Review reports

Original Submission
5 Nov 2015	Submitted	Original manuscript
23 Jan 2016	Reviewed	Reviewer Report - Rutika Mehta
24 Jan 2016	Reviewed	Reviewer Report - Susan Fineberg
11 Feb 2016	Author responded	Author comments - Alexander Brodsky
Resubmission - Version 2
11 Feb 2016	Submitted	Manuscript version 2
Publishing
7 Apr 2016	Editorially accepted
18 Apr 2016	Article published	10.1186/s12885-016-2302-5

Back to article page